National Football Champion Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

Former NFL Player Derek Kennard Aims to Spread Awareness on Benefits of CBD

SAN DIEGO, Oct. 1, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former Dallas Cowboys offensive lineman and Super Bowl champion Derek Kennard has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of cannabidiol (CBD) for athletes and active consumers.

“We look forward to working with Derek Kennard to continue our goal of spreading awareness and increasing public education about the health benefits of CBD,” said Kannaway® CEO Blake Schroeder. “Kennard is just one of many who have seen amazing health results while using CBD oil and we aim to use his story to inspire others.”

Kannaway® is the first hemp lifestyle network to legally offer hemp-based botanical CBD wellness products. The Kannaway® Sports division aims to spread awareness of the many important benefits CBD holds for professional and amateur athletes, connecting former NFL athletes with the education and products they need to help them live happier, more fulfilling lives. Kannaway® reported its largest-ever sales revenue quarter in company history in Q2 2018, as well as reached major milestones in their business operations.

“CBD oil allows me to get along with my day and have an improved quality of life,” said Kannaway® spokesperson Derek Kennard. “If someone was skeptical about taking CBD, I’d tell them that it’s not marijuana and it definitely won’t get them high. It’s become a great safe and natural alternative for me and I am thankful that these are high-quality products.”

Kennard recently added Kannaway® Pure Gold CBD Oil to his daily routine and has experienced firsthand how CBD can help manage his body’s wear and tear from playing football for most of his life. He’s also seen how it helps him be more relaxed each day, which helps him in his role as a public figure speaking at events.

“We are grateful to hold public partnerships such as this one that allow us to increase education and access to CBD in the U.S.,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. “It is our hope that through these partnerships and personal stories, people understand the wellness benefits of CBD.”

You can learn more about Derek Kennard and the other members of the Kannaway® Sports team here. For more information about Kannaway®, please visit

About Kannaway® 

Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]